Latest News
Oxford Biomedica swings to profit on Covid-19 vaccine sales
Covid-19 vaccine producer Oxford Biomedica swung to a profit in the half year on the back of a surge in revenues through its partnership deal with AstraZeneca and announced that Serum Institute of India has agreed to invest £50m in the group in return for a 3. 9% stake in the company.
Carnival's Princess and P&O brands extend pause in Australia to mid-January
Cruise operator Carnival said on Wednesday that both its Princess and P&O brands had paused vacations in Australia until mid-January 2022.
Saga posts small H1 pre-tax profit, withholds FY guidance amid continued pandemic uncertainty
Over 50s specialist Saga posted a small interim pre-tax profit on Wednesday but opted to issue no guidance as a result of the ongoing Covid-19 pandemic.
Berenberg raises target price on Draper Esprit
Analysts at Berenberg raised their target price on software firm Draper Esprit from 1,000. 0p to 1,200. 0p on Wednesday, stating the group was "continuing to move in the right direction".
US existing home sales decline in August
Existing home sales fell in August, with supply remaining constrained and prices accelerating further.
Canaccord reiterates 'buy' rating on Quixant following 'encouraging progress'
Analysts at Canaccord Genuity reiterated their 225. 0p target price on technology outfit Quixant on Wednesday, citing some "encouraging progress" despite margin headwinds.
London close: Stocks positive ahead of Federal Reserve decision
London stocks closed in the green on Wednesday, as concerns about embattled Chinese property giant Evergrande eased, and investors turned their attention to the latest policy announcement from the US Federal Reserve due later in the global day.
Netflix snaps up works of Roald Dahl
Netflix has secured the rights to the work of children’s favourite Roald Dahl, author of Charlie and the Chocolate Factory, Matilda and the Big Friendly Giant.
US open: Stocks trade higher ahead of FOMC decision
Wall Street trading got off to a positive start on Wednesday as market participants await this evening's Federal Reserve interest rate decision with bated breath.
Europe close: Shares close in bullish mood ahead of Fed meeting
European stocks closed in bullish mood on Wednesday ahead worries over Asian property developer China Evergrande abated slightly and investors turned their attention to the latest policy announcement from the US Federal Reserve due later in the day.
Clinigen to distribute 'Copiktra' in most of Europe
Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of ‘Copiktra’ in most of Europe, it announced on Wednesday.
Plant Health Care to launch 'Saori' with Brazil partner
Biological agriculture products company Plant Health Care announced a “key milestone” on Wednesday, through a new partnership with Nutrien Ag Solutions to launch its novel ‘Saori’ soybean seed treatment in Brazil.
Alba makes progress at Clogau-St David's
Alba Mineral Resources updated the market on progress of its development plans at the Clogau-St David's Gold Mine on Wednesday, for the extension of underground workings to key production targets Llechfraith Payshoot and Jack Williams, New Branch, 7-10 and Grandfathers Lodes.
Broker tips: BHP, Draper Esprit, Quixant
Bank of America Merrill Lynch downgraded BHP to 'neutral' from 'buy' on Wednesday and slashed its price target on the stock to 1,900. 0p from 2,900. 0p as it said earnings downgrades were coming.
Alien Metals pleased with maiden resource at Hancock
Minerals exploration and development company Alien Metals updated the market on its Hancock Iron Ore Project in the Pilbara region of Western Australia on Wednesday, specifically the publication of a maiden inferred resource of more than 10 million tonnes.
Thursday preview: BoE policy announcement in focus
All eyes will be on the Bank of England's policy announcement on Thursday.
Director dealings: K3 Business Technology director ups stake via Kestrel interest
K3 Business Technology revealed on Wednesday that Kestrel Partners, of which non-executive director Oliver Scott holds a beneficial interest, had purchased 99,615 ordinary shares in the AIM-listed software solutions group.
FTSE 250 movers: Oxford Biomedica surges; PZ Cussons under pressure
London’s FTSE 250 was up 0. 9% at 23,812. 07 in afternoon trade on Wednesday.
FTSE 100 movers: Entain rallies on deal news; Kingfisher falls again
London’s FTSE 100 was 1. 5% firmer at 7,082. 62 in afternoon trade on Wednesday.
Pret A Manger to double in size after securing £100m
Pret a Manger plans to double in size after securing £100m in fresh funding, the sandwich chain said on Wednesday.